表紙
市場調查報告書
商品編碼
877609

鼻出血設備的全球市場:2019年∼2023年

Global Epistaxis Device Market 2019-2023

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 136 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

嗅覺功能障礙已經影響到世界上數百萬人,主要是由於空氣污染造成的。嗅覺功能障礙會降低生活質量並導致各種神經退化性疾​​病。長期暴露於空氣污染物會增加嗅覺缺失或嗅覺減退的風險,並誘導嗅球中的細胞毒性和炎症性變化。由於空氣污染上升而頻繁流鼻血會增加對鼻出血設備的需求。這將導致全球鼻出血設備市場在預測期內以近6%的年複合成長率成長。

本報告提供全球鼻出血設備市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各應用領域

  • 市場區隔:各應用領域
  • 各應用領域比較:市場規模及預測(2018年∼2023年)
  • 前部鼻出血
  • 後部鼻出血
  • 市場機會:各應用領域

第7章 市場區隔:各類型

  • 市場區隔:各類型
  • 各類型比較:市場規模及預測(2018年∼2023年)
  • 鼻子棉塞
  • 經鼻導管
  • 其他
  • 市場機會:各類型

第8章 客戶形勢

第9章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第10章 決策架構

第11章 成長要素與課題

  • 市場成長要素
  • 市場課題

第12章 市場趨勢

  • 引起鼻出血的血液疾病的盛行率
  • 患高血壓的孕婦的比例增加
  • 功能性內視鏡下鼻竇手術(多功能鼻內窺鏡技術)後所使用的鼻出血設備的材料中的技術進步

第13章 業者情勢

  • 概要
  • 創造性破壞狀況

第14章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • DeRoyal Industries Inc.
  • Medtronic Plc
  • Pfizer Inc.
  • Smith & Nephew Plc
  • Stryker Corp.
  • Teleflex Inc.

第15章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第16章 關於TECHNAVIO

目錄
Product Code: IRTNTR31477

About this market

Epistaxis device includes nasal packing devices that are used in the treatment and prevention of nosebleeds. Technavio's epistaxis device market analysis considers the applications of epistaxis devices in anterior epistaxis and posterior epistaxis. Our analysis also finds the sales of the epistaxis device in North America, Europe, Asia, and ROW. In 2018, the anterior epistaxis segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising cases of epistaxis will play a significant role in the anterior epistaxis segment to maintain its market position. Also, our global epistaxis device market report looks at factors such as the increase in a number of patients with nasal and sinus cancers, a rise in the prevalence of high BP, and increasing air pollution. However, the availability of alternatives, side effects of nasal packing, and lack of awareness about epistaxis treatment may hamper the growth of the epistaxis device industry over the forecast period.

Overview

Increasing air pollution

Olfactory dysfunction, which has affected millions of people in the world, is mainly caused due to air pollution. Olfactory dysfunction reduces the quality of life and causes various neurodegenerative diseases. Prolonged exposure to air pollutants increases the risk of anosmia or hyposmia and induces cytotoxic and inflammatory changes in the olfactory bulb. The frequent nosebleeds due to rising air pollution will increase the demand for epistaxis device. This will lead to the growth of the global epistaxis device market at a CAGR of almost 6% during the forecast period.

Technological advances in materials of epistaxis device used after FESS

Functional endoscopic sinus surgery (FESS) is associated with complications such as nasal bleeding and adhesions, which increases the need for nasal packing. This has encouraged the development of advanced FESS nasal packing materials such as absorbent silver ions and chitosan scaffolds. These materials provide high patient comfort and satisfaction, reduces the recovery time, and improves the success rate of FESS. Thus, the technological advancements in materials will positively impact the growth of the epistaxis market during the forecast period.

For the detailed list of factors that will drive the global epistaxis device market during the forecast period 2019-2023.

Competitive Landscape

With the presence of several major players, the global epistaxis device market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading epistaxis device manufacturers, that include DeRoyal Industries Inc., Medtronic Plc, Pfizer Inc., Smith & Nephew Plc, Stryker Corp., and Teleflex Inc.

Also, the epistaxis device market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY APPLICATION

  • Market segmentation by application
  • Comparison by application
  • Anterior epistaxis - Market size and forecast 2018-2023
  • Posterior epistaxis - Market size and forecast 2018-2023
  • Market opportunity by application

PART 07: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Nasal tampons - Market size and forecast 2018-2023
  • Nasal catheters - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Prevalence of blood disorders causing epistaxis
  • Increasing proportion of pregnant women suffering from hypertension diseases
  • Technological advances in materials of epistaxis device used after FESS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • DeRoyal Industries Inc.
  • Medtronic Plc
  • Pfizer Inc.
  • Smith & Nephew Plc
  • Stryker Corp.
  • Teleflex Inc.

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global medical devices market
  • Exhibit 02: Segments of global medical devices market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ thousands)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Application - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by application
  • Exhibit 19: Anterior epistaxis - Market size and forecast 2018-2023 ($ thousands)
  • Exhibit 20: Anterior epistaxis - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Posterior epistaxis - Market size and forecast 2018-2023 ($ thousands)
  • Exhibit 22: Posterior epistaxis - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Market opportunity by application
  • Exhibit 24: Type - Market share 2018-2023 (%)
  • Exhibit 25: Comparison by type
  • Exhibit 26: Nasal tampons - Market size and forecast 2018-2023 ($ thousands)
  • Exhibit 27: Nasal tampons - Year-over-year growth 2019-2023 (%)
  • Exhibit 28: Nasal catheters - Market size and forecast 2018-2023 ($ thousands)
  • Exhibit 29: Nasal catheters - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Others - Market size and forecast 2018-2023 ($ thousands)
  • Exhibit 31: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Market opportunity by type
  • Exhibit 33: Customer landscape
  • Exhibit 34: Market share by geography 2018-2023 (%)
  • Exhibit 35: Geographic comparison
  • Exhibit 36: North America - Market size and forecast 2018-2023 ($ thousands)
  • Exhibit 37: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: Europe - Market size and forecast 2018-2023 ($ thousands)
  • Exhibit 39: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 40: Asia - Market size and forecast 2018-2023 ($ thousands)
  • Exhibit 41: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 42: ROW - Market size and forecast 2018-2023 ($ thousands)
  • Exhibit 43: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 44: Key leading countries
  • Exhibit 45: Market opportunity
  • Exhibit 46: Impact of drivers and challenges
  • Exhibit 47: Vendor landscape
  • Exhibit 48: Landscape disruption
  • Exhibit 49: Vendors covered
  • Exhibit 50: Vendor classification
  • Exhibit 51: Market positioning of vendors
  • Exhibit 52: DeRoyal Industries Inc. - Vendor overview
  • Exhibit 53: DeRoyal Industries Inc. - Organizational developments
  • Exhibit 54: DeRoyal Industries Inc. - Key offerings
  • Exhibit 55: Medtronic Plc - Vendor overview
  • Exhibit 56: Medtronic Plc - Business segments
  • Exhibit 57: Medtronic Plc - Organizational developments
  • Exhibit 58: Medtronic Plc - Geographic focus
  • Exhibit 59: Medtronic Plc - Segment focus
  • Exhibit 60: Medtronic Plc - Key offerings
  • Exhibit 61: Pfizer Inc. - Vendor overview
  • Exhibit 62: Pfizer Inc. - Business segments
  • Exhibit 63: Pfizer Inc. - Organizational developments
  • Exhibit 64: Pfizer Inc. - Geographic focus
  • Exhibit 65: Pfizer Inc. - Segment focus
  • Exhibit 66: Pfizer Inc. - Key offerings
  • Exhibit 67: Smith & Nephew Plc - Vendor overview
  • Exhibit 68: Smith & Nephew Plc - Business segments
  • Exhibit 69: Smith & Nephew Plc - Organizational developments
  • Exhibit 70: Smith & Nephew Plc - Business segments
  • Exhibit 71: Smith & Nephew Plc - Geographic focus
  • Exhibit 72: Smith & Nephew Plc - Segment focus
  • Exhibit 73: Smith & Nephew Plc - Key offerings
  • Exhibit 74: Stryker Corp. - Vendor overview
  • Exhibit 75: Stryker Corp. - Business segments
  • Exhibit 76: Stryker Corp. - Organizational developments
  • Exhibit 77: Stryker Corp. - Geographic focus
  • Exhibit 78: Stryker Corp. - Segment focus
  • Exhibit 79: Stryker Corp. - Key offerings
  • Exhibit 80: Teleflex Inc. - Vendor overview
  • Exhibit 81: Teleflex Inc. - Business segments
  • Exhibit 82: Teleflex Inc. - Organizational developments
  • Exhibit 83: Teleflex Inc. - Geographic focus
  • Exhibit 84: Teleflex Inc. - Segment focus
  • Exhibit 85: Teleflex Inc. - Key offerings
  • Exhibit 86: Validation techniques employed for market sizing
  • Exhibit 87: Definition of market positioning of vendors